Showing results (101-110 of 120) with videos related to
Sort By:
Pageof 12
British Journal of Cancer|September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein bindingN J Curtin, K J Bowman, R N Turner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Carboplatin dosage: prospective evaluation of a simple formula based on renal functionA H Calvert, D R Newell, L A Gumbrell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2023
Carboplatin dosage: prospective evaluation of a simple formula based on renal functionA H Calvert, D R Newell, L A Gumbrell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study GroupD R Newell, A D Pearson, K Balmanno, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group TrialH Thomas, A V Boddy, M W English, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell linesM J Barnes, E J Estlin, G A Taylor, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidoneP A Speth, M E Gore, A J Pateman, et al.Journal of Medicinal Chemistry|October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituentT R Jones, A H Calvert, A L Jackman, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)A H Calvert, D R Newell, A L Jackman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717A H Calvert, D L Alison, S J Harland, et al.Pageof 12